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ABSTRACT: The materials used for internal fracture fixations and joint replacements are 
mainly made of metals which still face problems ranging from higher rigidity than that of 
natural bone to leaching cytotoxic metallic ions. Beta (β)-type titanium alloys with low elastic 
modulus made from non-toxic and non-allergenic elements are desirable to reduce stress 
shielding effect and enhance bone remodeling. In this work, a new β-type Ti-23Nb-0.7Ta-
2Zr-0.5N alloy with a Young’s modulus of approximately 50 GPa was designed and 
characterized. The behavior of MC3T3-E1 pre-osteoblasts on the new alloy, including 
adhesion, proliferation and differentiation, was evaluated by examining the cytoskeleton, 
focal adhesion formation, metabolic activity and extracellular matrix mineralization. Results 
indicated that the pre-osteoblast cells exhibited a similar degree of attachment and growth on 
Ti-23Nb-0.7Ta-2Zr-0.5N and Ti-6Al-4V. However, the novel alloy proved to be significantly 
more efficient in sustaining mineralized matrix deposition upon osteogenic induction of the 
cells than Ti-6Al-4V control. Further, analysis of RAW 264.7 macrophages cytokine gene 
and protein expression indicated no significant inflammatory response. Collectively, these 
findings suggest that the Ti-23Nb-0.7Ta-2Zr-0.5N alloy, which has an increased mechanical 
biocompatibility with bone, allows a better osteogenic differentiation of osteoblast precursor 
cells than Ti-6Al-4V and holds great potential for future clinical prosthetic applications. 
 
Keywords: beta-titanium alloy; osteoblast; differentiation; macrophage; inflammatory 
response. 
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1. Introduction 
 
Titanium (Ti) alloys are well established materials of choice for medical applications 
such as joint replacements, bone screws and plates, dental implants and surgical components 
due to their good mechanical properties and biocompatibility [1]. However, Young’s moduli 
of the widely used Ti-based implant devices are generally higher than that of human bone 
which affects long-term practical performances due to the stress shielding phenomenon [2]. 
The effects associated with stress shielding at the level of bone-implant system create 
multiple undesired phenomena and may finally lead to contact loosening, premature implant 
failure or debris-induced infections [3]. This explains why in the design of Ti alloys for 
biomedical applications, the reduction of the elastic stiffness must be regarded as a high 
priority constraint in the overall strategy. Studies conducted in vivo have proved that Ti-based 
alloys with low Young’s modulus are effective for inhibiting bone atrophy and enhancing 
bone formation [4-6]. Also, there is much effort currently dedicated to replace with safer 
alloying elements aluminium and vanadium from commercial Ti bioalloys due to their 
cytotoxicity [7, 8], providing better mechanical properties, reducing elastic modulus closer to 
that of the human bone, while retaining high strength in the new alloys. Consequently, a new 
generation of low modulus β-Ti alloys, which are free of vanadium and aluminium is being 
developed with β-stabilizing and biocompatible elements such as Nb, Ta and Zr [9-19]. 
On the other hand, it was reported in literature that in a given composition domain, the 
quenched β microstructure is decomposed into a stress-induced alpha'' martensite when an 
external stress is applied. This phenomenon is generally highlighted by a characteristic tensile 
stress-strain curve showing a nonlinear elastic domain and a stress plateau associated with a 
double yielding behavior. As the stress-induced martensitic transformation is reversible, a 
high recoverable strain can be obtained, leading to a superelastic effect [20-22]. The super-
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elastic behavior of these materials may provide benefits especially for joint replacements who 
are subjected to cyclical stresses during daily activities. Moreover, the super-elastic effect 
could be used to help anchor the implant within the receiving bone cavity. To our knowledge, 
there has been only one study reporting on the in vivo super-elastic biomechanics and 
corresponding osteointegration effects. Liu et al. [23] compared the performance of porous 
nitinol with that of porous titanium, dense nitinol and dense titanium. They found that porous 
nitinol fosters fast bone ingrowth and osteointegration, and the bonding strength is enhanced 
significantly compared to other metallic implants including porous titanium, characterized by 
a lower Young’s modulus and a bioactive surface layer, which does not possess super-
elasticity. This superelastic effect is accompanied by a very significant reduction of the 
elastic modulus, which is highly beneficial for the use of these alloys like prostheses or 
implants in osseous sites.  On the other hand, these non-allergen Ni-free alloys can be 
envisaged to replace the superelastic NiTi-based materials currently used for the fabrication 
of functional biomedical dispositives such as cardiovascular stents or orthopedic staples, for 
example. 
In this context, the aim of the present study was to assess the cellular response to the 
newly developed low modulus superelastic β-type Ti-23Nb-0.7Ta-2Zr-0.5N alloy 
composition. Two different cell types were used: MC3T3-E1 pre-osteoblasts and RAW 264.7 
macrophages. The latter cell type was used to determine potential inflammatory responses to 
the materials by measuring release of the pro-inflammatory cytokines and chemokines such 
as tumor necrosis factor (TNF)-α, interleukin (IL)-6, monocyte chemotactic protein (MCP)-1 
and regulated upon activation normal T cell expressed and secreted (RANTES). Gene 
expression analysis of these molecules has also been performed. For comparative purposes, 
Ti-6Al-4V was used as a control. Osteoblasts response to 23Nb-0.7Ta-2Zr-0.5N alloy was 
evaluated in terms of cell attachment and spreading, cell morphology, cell proliferation, and 
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matrix mineralization in order to prove its suitability as bone implant material. Also, the 
microstructure, composition and the mechanical properties investigated by tensile tests of the 
Ti-23Nb-0.7Ta-2Zr-0.5N alloy are presented and discussed. 
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2. Materials and methods 
 
2.1. Alloy synthesis and characterization 
 
The Ti-23Nb-0.7Ta-2Zr-0.5N alloy (chemical composition given in at. % with the 
balance Ti) was synthesized by cold crucible levitation melting technique (CCLM) under 
high vacuum. Ingots obtained from melting were next homogenized at 1223 K for 72 x 10
3 
s 
under high vacuum, followed by water quenching. Ingots were then cold rolled at room 
temperature until a 90% of reduction in thickness was achieved. From this cold-rolled state, 
samples were cut in disc shape pieces for the biological tests or machined into flat tensile 
specimens for the tensile tests. Finally, all samples were solution-treated in the β-phase 
domain at 1123K for 1.8 x 10
3 
s under vacuum in order to restore a fully recrystallized 
microstructure and water quenched to retain the metastable beta microstructure at room 
temperature. 
For the biological tests, disc-shaped samples, with a disc diameter of 13 mm and a 
thickness of 1mm, were mechanically polished on silicon carbide abrasive papers (up to 4000 
grit) and then ultrasonically cleaned in acetone, thoroughly washed with ethanol and dried in 
air. For comparison, the commercially Ti-6Al-4V alloy (Goodfellow supplier) was chosen as 
reference and samples from this alloy were prepared similarly.  
Roughness of the samples used for the biological tests were evaluated by atomic force 
microscopy (AFM, CSM Instruments). For that, tapping mode was used in air with a silicon 
tip. To evaluate the roughness, 12 measurements were obtained from 83 x 83 μm AFM scans 
taken from each sample surface.  
The measurements of water contact angle, which plays an important role in determining 
the dynamics of protein-surface interaction, surface fouling and cell-substrate responses [24], 
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were performed according to ASTM D7334 – 08 [25] using Contact Angle Meter KSV 
Instruments CAM 100. Each contact angle value is the average of minimum 10 frames with 
the frame interval up to 100 ms; the drop volume was 3 μL. The investigation was carried out 
with an accuracy of ± 1
o
 at a temperature of 25 
o
C. 
The Ti-23Nb-0.7Ta-2Zr-0.5N alloy microstructure was observed by optical microscopy 
(LEICA DM/RM). To be observed, the sample was polished to a final “mirror” polishing 
state using a colloidal silica suspension (particles size: 50 nm) and was etched in an acid 
solution containing 5%HNO3, 5%HF and 90% H2O to reveal the microstructure.  
Surface analysis performed by X-Ray Photoelectron Spectroscopy (XPS) was carried out 
on a Quantera SXM equipment, with a base pressure in the analysis chamber of 10
-9
 Torr. 
The X-ray source was Al Kα radiation (1486.6eV, monochromatized) and the overall energy 
resolution was estimated at 0.6 eV by the full width at half maximum (FWHM) of the Au4f7/2 
line. In order to take into account the charging effect on the measured Binding Energies 
(BEs), the spectra were calibrated using the C1s line (BE = 284.8 eV, C-C (CH)n bondings) 
of the adsorbed hydrocarbon on the sample surface. A dual beam (electrons and Ar 
+
) was 
used for a complete neutralization of the surface. 
Tensile tests until rupture were carried out using an INSTRON 3369 machine with a 
strain rate of 10
-4
 s
-1
. An extensometer was used to precisely measure the deformation of the 
specimens. In addition, the superelastic behavior of the alloy was characterized from cyclic 
tensile tests with strain increments of 0.5% followed by stress release up to an elongation of 
4% (loading-unloading cycles). Tensile specimens were machined to obtain normalized 
shapes: 3 mm width, 0.5 mm in thickness and a gage length of 15 mm. 
 
2.2. Cell cutures 
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Mouse pre-osteoblast MC3T3-E1 (American Type Culture Collection) and mouse 
macrophage RAW 264.7 (American Type Culture Collection) cell lines were cultured in 
Dulbecco’s Minimal Essential Medium supplemented with 10% (v/v) foetal bovine serum 
and 1% (v/v) penicillin/streptomycin (10,000 units/mL penicillin and 10 mg/mL 
streptomycin). Both cell lines were incubated at 37 °C in a humidified atmosphere of 5% CO2 
for specific times. Pre-osteoblastic MC3T3-E1 cells were seeded onto metallic specimens 
placed in 12-well cell culture plates at a density of 10
4
 cells/cm
2
 for cell attachment and 
spreading, cell morphology and cell proliferation studies, while macrophage-like RAW 264.7 
cells were plated on test alloys at a density of 2.5 x 10
4
 cells/cm
2
 in two different conditions: 
non-inflammatory and pro-inflammatory using 10 ng/ml of Escherichia coli 
lipopolysaccharide (LPS). All cell culture-based assays were conducted in triplicate for each 
sample. 
 
2.3. Fluorescence labeling of actin and vinculin 
 
After 3 h and 24 h of culture, the osteoblasts grown on Ti alloys were fixed with 4% 
paraformaldehyde prepared in phosphate buffered saline (PBS), permeabilized and blocked 
with 0.1% Triton X-100/ 2% bovine serum albumin for 30 min. and washed with PBS. The 
samples were then incubated with vinculin antibody (Santa Cruz Biotechnology, dilution 
1:50) for 2 h at room temperature, washed again with PBS and incubated for 1 h with 
AlexaFluor488-conjugated specific secondary antibody (Invitrogen, dilution 1:200). 
Afterwards, phalloidin-TRITC (tetramethylrhodamine B isothiocyanate) (10 μg/ml; Sigma–
Aldrich) was added, and the samples were incubated at room temperature for 15 min. The 
labelled cells were washed three times with PBS and examined by using Olympus IX71 
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microscope equipped for epifluorescence. The images were captured by means of Cell F 
image acquiring system. 
 
2.4. Cell viability and proliferation 
 
Viability of MC3T3-E1 and RAW 264.7 cells was evaluated after 2, 4, 7 and 1, 2 days of 
culture, respectively. This study was conducted by MTT colorimetric assay which also 
provides a useful indication of cell proliferation rates. To perform MTT assay, the solution of 
3- (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in serum free culture medium 
(1 mg/ml) was added into wells being assayed, and the cells were incubated for another 3 h at 
37 °C. Then, the MTT solution was decanted and formazan crystals were solubilized with 1 
ml of dimethyl sulfoxide. Absorbance of dye was measured at a wavelength of 550 nm and 
recorded using a microplate reader (Thermo Scientific Appliskan).  
 
2.5. Pre-osteoblast differentiation on the titanium alloys 
 
For differentiation assay, pre-osteoblastic cells were seeded onto samples at a density of 5 
x 10
4
 cells/cm
2
. 24 h post-seeding, differentiation was induced by maintaining the cells in 
culture media supplemented with 50 µg/ml ascorbic acid (AA) (Sigma-Aldrich) and 5 mM 
beta-glycerophosphate (β-GP) (Sigma-Aldrich). The medium was changed three times per 
week during the culture period. Cell differentiation was evaluated after 2, 4 and 6 weeks of 
culture by Alizarin red staining for matrix mineralization. The cell layers were washed twice 
with PBS, fixed with 10% formalin solution for 20 min, and then washed with pure water 
three times. For Alizarin red S staining, the cells were placed in 1mg/ml Alizarin red S 
(Sigma-Aldrich) solution for 30 min. After stain removal and washing the samples with 
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distilled water, gross view photographs were taken using Nikon D3000 digital camera. Then, 
the cells were air-dried and deposited calcium was quantified by removing the Alizarin stain 
with 5 % v/v perchloric acid for 10 min and reading the absorbance of the resulting solution 
at 405 nm. 
 
2.6. Quantitative Polymerase Chain Reaction (qPCR) 
 
Cells were harvested from the samples at 24 h and 48 h post-seeding. Total RNA from 
RAW 264.7 cells was isolated using RNA PureLink Mini Kit (Ambion, Life Technologies, 
Foster City, CA, USA), according to the manufacturer’s protocols and tested for integrity on 
BioAnalyzer 2100 (Agilent Technologies, Waldbronn, Germany) and purity on NanoDrop 
spectrophotometer (Shimadzu, Duisburg, Germany). One microgram of total cellular RNA 
was reverse transcribed to corresponding cDNA using iScript cDNA Synthesis kit (BioRad, 
Hercules, CA, USA). Sequences of gene-specific primers used in qPCR assay are presented 
in Table 1 along with the sequences designed for the GAPDH reference gene. The melting 
temperature optimization for these primers was carried out based on standard PCR 
components (GoTaq DNA Polymerase kit) provided by Promega, Madison, WI, USA via 
gradient PCR on a Corbett thermocycler, in 52–62°C range of temperatures. The gradient 
PCR amplicons were subjected to 2% agarose electrophoresis, followed by ethidium bromide 
(Roth, Karlsruhe, Germany) staining. The relative gene expressions of IL-6, TNF-α, MCP-1 
and RANTES markers of the inflammation process were assessed by RealTime RT-PCR on a 
LightCycler 2.0 carrousel-based system using LightCycler Fast Start DNA Master SYBR 
Green I Kit (Roche, Mannheim, Germany). 
  
2.7. Quantification of cytokines and chemokines secreted 
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 Commercially available enzyme-linked immunosorbent assay (ELISA) kits (R&D 
Systems) were used to determine the concentrations of secreted TNF-α, IL-6, MCP-1 and 
RANTES according to package insert instructions. To eliminate variation due to differences 
in cell viability, concentrations were expressed in relation to the number of control cells, 
according to MTT results, as follows: normalized pg/ml
 
= measured pg/ml × (control cells 
MTT OD/sample cells MTT OD). Secreted cytokine production was measured in 
supernatants harvested at 24 h and 48 h post-seeding. 
 
2.8. Statistical analysis 
 
Statistical analysis of the data was performed with GraphPrism software using one-way 
ANOVA with Bonferroni’s multiple comparison tests. All results are expressed as means ± 
SD (standard deviation) and p values of less than 0.05 were considered statistically 
significant.  
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3. Results and discussion 
 
A very important criterion for selecting an implantable biomaterial is represented by its 
biocompatibility. Our studies have investigated pre-osteoblast and macrophage responses to 
the newly developed superelastic β-type Ti-23Nb-0.7Ta-2Zr-0.5N alloy. 
 
3.1. Alloy characterization 
 
Fig. 1 shows an optical micrograph displaying the typical microstructure of the solution-
treated and quenched Ti-23Nb-0.7Ta-2Zr-0.5N alloy. As it can be observed, the 
microstructure consists of a fully β-grain microstructure with a grain dimension varying 
between a few tens to a few hundreds of micrometers. 
XPS analysis in Survey mode was used to determine the chemical elements present on the 
surface (< 10nm) and, after quantitative analysis, to determine their relative concentrations, 
as well. It is appropriate to note here that all the calculations were performed assuming that 
the sample was homogeneous within the XPS detected volume. We have to emphasize that 
the errors in our quantitative analysis (relative concentrations) were estimated in the range of 
± 10 %, while the accuracy for Binding Energies (BEs) assignments was ± 0.2 eV. The 
spectral signatures (BEs)  (Fig. 2 and Table 2) display the presence on the surface of a native 
oxide layer (~ 9.0 nm in depth) with Ti, Zr and Nb in their full oxidation states , while Ta 
exhibits  suboxide states (a mixture of TaO and Ta2O3). The surface stoichiometry calculated 
by XPS quantification is found in good agreement with the nominal (bulk) stoichiometry. 
Nevertheless, nitrogen is found in excess leading to the conclusion that during thermal 
treatment a segregation effect from the bulk to the surface occurs. However, a small 
contribution from the nitrogen adsorption found in the atmosphere cannot be ruled out. It is 
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worth to notice that besides the unavoidable surface contamination with carbon from 
hydrocarbons and CO2 adsorbed from environment, no other contaminant was found on the 
surface leading to the conclusion that the surface is stable and clean even in the “as received” 
state. 
In Fig. 3, it is reported a typical stress-strain curve until rupture obtained from the Ti-
23Nb-0.7Ta-2Zr-0.5N alloy by tensile test. On the other hand, the cyclic tensile curve 
between 0 and 4% of strain is also presented in this figure (center part) in order to 
characterize properly the superelastic behavior of such alloy. It is necessary to note the 
excellent repeatability of the mechanical experiments because very similar strain-stress 
tensile curves were obtained for the five tests carried. Only a significant difference 
concerning the elongation at rupture was observed (around 5%) due to the fact that the 
rupture can be strongly influenced by the surface preparation inducing sometime crack 
ignition sites. It can be clearly observed the nonlinearity of the elastic domain and the 
presence of hysteresis loops between each loading-unloading cycle, which is characteristic of 
the superelastic property possessed by such alloy. From this curve an important elastic 
recovery at about 2.2% was evaluated and a low incipient Young’s modulus measured at 50 
GPa was found, which is very low compared to that obtained from classical titanium alloys 
currently used in medicine (110 GPa for Ti-6Al-4V) and closer to the one that corresponds to 
the cortical bone (20-30 GPa). These good properties are due to the fact that a stress-induced 
martensitic transformation occurred in this alloy. As observed in literature [20], this 
transformation is accompanied by a significant reduction of the Young’s modulus and a large 
elastic recovery due to its reversible character. On the other hand, the tensile curve shows 
both high yield strength and ultimate tensile strength, which are almost twice higher in 
comparison with binary the Ti-26Nb alloy reported from literature [21]. This strengthening, is 
due to the fact that nitrogen, as interstitial element, is well known to involve a solid-solution 
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hardening effect in alloys. In addition, it can be noticed that nitrogen addition leads also to a 
higher superelasticity (almost by 1.5 higher) in comparison with the Ti-Nb, Ti-Nb-Ta or Ti-
Nb-Ta-Zr superelastic alloys reported from literature [9, 11, 13, 20-22, 24]. Consequently, 
this new Ti-23Nb-0.7Ta-2Zr-0.5N alloy, combining high strength, high superelasticity, low 
modulus and good ductility, is very interesting for a use in medicine. 
Examples of AFM maps showing the surface topography of each polished alloy are 
presented in Fig. 4. From all AFM maps obtained (12 from each alloy composition), the 
roughness value, Ra, was evaluated to be 98±7 nm and 89±6 nm for Ti-23Nb-0.7Ta-2Zr-
0.5N and Ti-6Al-4V, respectively. Thus, very close roughness values in the nanometer range 
were found on the surface of these two alloys which can minimize any influence of surface 
topography on cell adhesion and function. Furthermore, water contact angle determination 
permitted the evaluation of wettability behavior for investigated samples. Both surfaces were 
found slightly hydrophilic with contact angles of 76.891 ± 1.201° and 72.821±1.129° for Ti-
23Nb-0.7Ta-2Zr-0.5N and Ti-6Al-4V, respectively. Therefore, we also can assume that any 
differences in cellular response between the two alloys are unlikely to be attributed to 
wettability, which is known to affect the adsorbed protein layer and, consequently, the events 
at cell-material interface. 
 
3.2. MC3T3-E1 cell adhesion and morphology 
 
Cell attachment, adhesion and spreading belong to the first phase of cell/material 
interactions and depend strongly on the physical and chemical properties of the biomaterial 
surface [26]. Moreover, the bioactivity and biocompatibility of biomaterials are very closely 
related to the behavior of cells in contact with them and, particularly, to cell adhesion to their 
surface [27]. While the attachment phase occurs rapidly and involves physicochemical bonds 
14 
 
such as ionic and Van der Waals forces between cells and materials, cell adhesion occurs 
over a longer term and is mediated through focal adhesions, which are large dynamic 
complexes of organized protein clusters that link the extracellular matrix (ECM) through 
integrin-ECM binding to the intracellular cytoskeleton [28, 29]. Furthermore, focal adhesions 
activate signaling pathways which control cell function and architecture [30]. Vinculin is a 
major protein of focal adhesions and a key player in the regulation of cell adhesion [31]. 
Therefore, vinculin provides a valuable detection system for focal adhesion sites by means of 
specific antibody detection. 
Cell morphology and adhesion were both investigated in this study to assess the 
biocompatibility of Ti-23Nb-0.7Ta-2Zr-0.5N substrate compared to Ti-6Al-4V in an in vitro 
environment. Organization of actin cytoskeleton was visualized by incubation with TRITC-
conjugated phalloidin, whereas focal adhesion formation was analyzed by 
immunocytochemistry using a monoclonal antibody against vinculin (Fig. 5).  
As shown in Fig. 5, three hours after seeding nearly all the cells, initially round, were 
spread and displayed cellular extensions in different directions. Over time adherent cells 
increased in area and gradually elongated. Thus, at 24 h after plating the cells exhibited a 
well-defined polygonal or spindle-shaped morphology, typical for osteoblasts. A high degree 
of cell attachment and spreading was observed on both alloys. Further on, high resolution 
fluorescence images showed a circumferential localization of actin filaments near the cell 
membrane at 3h post-seeding. Moreover, at this time point, the cytoskeleton began to show a 
pattern of parallel-orientated actin filaments which later developed into well-defined 
arrangements of actin stress fibres oriented in a parallel direction following the main cellular 
axis. No significant differences in the cytoskeletal framework were observed between 
materials. Furthermore, almost similar patterns of vinculin staining were observed on both 
alloys. Thus, at 3 h post-seeding, vinculin staining signals were localized to cytoplasmic 
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regions showing predominantly a punctiform pattern which suggests formation of focal 
contacts between plasma membrane and extracellular proteins adsorbed to both material 
surfaces. In the MC3T3-E1 cells cultured for 24 h, immunoreactive sites for vinculin were 
found in the peripheral regions of the cells, predominantly at the termini of actin 
microfilament bundles resulting in focal adhesion patches, and displaying punctiform pattern 
at the subcellular level in the plasma membrane near the nucleus area.  
 Taken together, these data show that cells responded to both materials in an almost 
identical manner, possibly due to similar topography, roughness and wettability of test 
materials. Thus, we can draw the conclusion that Ti-23Nb-0.7Ta-2Zr-0.5N alloy is a suitable 
substrate for cell attachment and adhesion, and allows a normal development of actin 
cytoskeleton. To the best of our knowledge, the cellular response to superelastic β-type 
titanium alloys has not been yet extensively investigated. Such a study has been performed by 
Arciniegas et al. [32] on the superelastic Ti19.1Nb8.8Zr alloy in comparison with Ti grade II 
(cpTi) and a β-type Ti41.2Nb6.1Zr. The in vitro studies were achieved on MG63 osteoblasts 
and conducted using both indirect and direct contact methods demonstrating that all three 
samples display a good short-term biological behavior in terms of cell viability and 
attachment. Noteworthy, the obtained results suggested that although no significant 
differences in the number of adherent viable osteoblasts were remarked, the speed of cell 
attachment was higher on the Ti19.1Nb8.8Zr alloy, followed by Ti41.2Nb6.1Zr and cpTi. 
 
3.3. Pre-osteoblast proliferation 
 
In order to evaluate if the Ti-23Nb-0.7Ta-2Zr-0.5N surface could affect proliferative 
activity, we monitored cell growth for up to 7 days with MTT assay (Fig. 6). Although the 
number of viable metabolically active cells was higher on control sample at all studied time 
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points, no statistically significant differences in cell proliferation activity between analyzed 
samples were found out. Moreover, a marked increase in the cell number with culturing time 
was observed on both alloys confirming their growth-supporting capacity. 
 
3.4. Matrix mineralization 
 
An essential requirement for a candidate material to significantly improve the speed of 
bone formation on its surface which will allow lowering the implant fixation time and the 
probability of implant failure is its ability to promote bone matrix maturation and 
mineralization. A hallmark of osteoblast differentiation both in vivo and in vitro is the 
formation of an extracellular matrix whose main component is calcium. Therefore, 
mineralization of osteogenic cultures is considered a functional in vitro endpoint reflecting 
advanced cell differentiation [33]. In this work, for evaluating in vitro osteogenic 
differentiation of cultured cells on Ti-23Nb-0.7Ta-2Zr-0.5N and Ti-6Al-4V substrates, 
qualitative staining and quantitative measurements have been used. Thus, extracellular matrix 
mineralization was quantified by Alizarin red staining at different time points and results are 
shown in Fig. 7. Cells seeded on both surfaces and maintained in growth culture medium 
failed to produce a mineralized matrix even after six weeks of culture. However, after 
induction in osteogenic medium it can be observed that our developed Ti-23Nb-0.7Ta-2Zr-
0.5N alloy promoted extracellular matrix secretion and mineralization at cell-material 
interface to a higher extent than Ti-6Al-4V alloy. At six weeks of culture in osteogenic 
conditions, the percent of Alizarin red S labeling area for Ti-23Nb-0.7Ta-2Zr-0.5N substrate 
was significantly larger than that for Ti-6Al-4V control. According to the quantitative results, 
matrix mineralization on Ti-6Al-4V represented about 42% of that on Ti-23Nb-0.7Ta-2Zr-
0.5N. A possible explanation for this observation is that ions released from biomaterials with 
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different chemical composition exert a significant differential effect on osteoblasts behavior. 
Thus, Thompson and Puleo [34] found that Ti-6Al-4V solutions strongly inhibit osteocalcin 
synthesis and reduce calcium levels. They concluded that ions associated with Ti-6Al-4V 
alloy inhibit the normal differentiation of bone marrow stromal cells to mature osteoblasts in 
vitro, and in vivo may contribute to implant failure by impairing normal bone deposition. 
More recently, Obata and Takahashi [35] demonstrated that cells cultured in the medium 
containing 3 × 10
-7
 M niobium ions display higher  alkaline phosphatase (ALP) activity in 
comparison with normal medium, regardless of the presence of osteogenic factors (ascorbic 
acid, β-glycerophosphate and dexamethasone) in the media. Moreover, calcium deposition by 
the cells cultured in the medium containing 3 × 10
-7
 M niobium ions was found to be twice as 
high as those cultured in medium containing no niobium ions. Also, previous studies of 
osteoblast behavior on Nb containing alloys indicated a very good in vitro cell response. For 
instance, Ti-6Al-7Nb was reported to support a more rapid maturation of osteoblasts 
compared to Ti-6Al-4V [36]. Subsequently, Guo et al. [37] investigated the bone tissue 
compatibility of a new Ti-35Nb-2Ta-3Zr alloy with a low Young's modulus. The in vitro 
analysis demonstrated increased cell proliferation, alkaline phosphatase activity, calcium 
deposition and mRNA expression of osteogenic genes (i.e., ALP, osteocalcin, osteopontin) on 
Ti-35Nb-2Ta-3Zr alloy compared to Ti-6Al-4V alloy. Only several in vivo studies have 
described the bone tissue compatibility of implants with low Young’s moduli. Thus, Guo et 
al. [38] studied the bone healing and stability of intramedullary nails made of Ti–24Nb–4Zr–
7.9Sn alloy implanted in New Zealand white rabbits. It was found that the low modulus of 
Ti–24Nb–4Zr–7.9Sn alloy leads to significant improvement in new bone formation in 
fractured rabbit tibiae as compared with the control group made of Ti–6Al–4V. Their 
findings suggest that, in the early days of fixation, nails made of low modulus Ti–24Nb–4Zr–
7.9Sn improved new bone formation in the marrow cavity. Shi et al. [39] used the 
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osteoporotic rabbit model induced by the combination of ovariectomy and glucocorticoid 
treatment to determine if the Ti–24Nb–4Zr–7.9Sn implant with low elastic modulus and high 
strength can relieve the stress shielding phenomenon and improve the implant survival time. 
Implants made of Ti–24Nb–4Zr–7.9Sn were found to possess better stability and bone-
implant interface than the TiAlV implants. Histological observations indicated direct bone-to 
implant contact with no fibrous tissue in the Ti–24Nb–4Zr–7.9Sn group at 12 weeks, proving 
that osseointegration were achieved. 
Our findings appear in line with the available literature in vitro data revealing that Ti-
23Nb-0.7Ta-2Zr-0.5N material exhibited good cell adhesion, spreading, proliferation, and 
enhanced matrix mineralization. Taking into consideration that our material showed 2.42 fold 
higher mineralization levels than Ti-6Al-4V, it might be a better option for orthopedic 
applications. 
 
3.5. Inflammatory response 
 
Implantation of a biomaterial immediately triggers an inflammatory response orchestrated 
by macrophages [40]. It is well known that substrate-adherent macrophages become activated 
in an attempt to phagocytose the biomaterial and that the subsequent cytokine secretion 
directs the inflammatory and wound healing responses to the biomaterial presence. Previous 
studies have revealed the important role of cytokines and chemokines in bone healing, 
through the influence exerted on the recruitment and differentiation of mesenchymal stem 
cells [41], and the migration and differentiation of osteoclasts [42, 43]. In general, a pro-
inflammatory cytokine profile is associated with both delayed bone healing and bone loss 
[44]. While it is subject of controversy whether implant surfaces should sustain macrophage 
adhesion, promote or inhibit macrophage responses, it is widely accepted that excessive 
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macrophage activation correlated with a pro-inflammatory cytokine profile affects implant 
bioperformance [45]. 
In the present work gene and protein analysis of the inflammatory cytokines and 
chemokines TNF-α, IL-6, MCP-1 and RANTES was performed by qPCR and ELISA, 
respectively, and used as a measure of inflammatory response. Results demonstrated 
differential cytokine gene expression on Ti-23Nb-0.7Ta-2Zr-0.5N and Ti-6Al-4V materials 
(Fig. 8a). In standard culture conditions, significant lower cytokine mRNA expression levels 
were noticed following 24 h of cell exposure to Ti-23Nb-0.7Ta-2Zr-0.5N when compared to 
Ti-6Al-4V for TNF-α and RANTES. Furthermore, addition of LPS showed a marked 
increase in pro-inflammatory cytokines expression by macrophages attached to Ti alloys. In 
pro-inflammatory conditions we found markedly enhanced expression of IL-6 and RANTES 
by Ti-6Al-4V when compared to Ti-23Nb-0.7Ta-2Zr-0.5N. However, after 48 h of culture, 
the expression of analyzed inflammatory markers was reduced and comparable in both 
samples suggesting the absence of a persistent inflammatory response. As regards to cytokine 
production, relatively low levels of cytokines were secreted by macrophages cultured on both 
surfaces in absence of exogenous stimuli. Conversely, cytokine release was strongly up-
regulated by the addition of LPS. Despite the remarked differences in cytokine gene 
expression, no significant changes at the level of cytokine release have been found between 
the analyzed samples (Fig. 8b). Considering that protein levels are the product of gene 
expression which has occurred 4–18 h earlier, direct correlation between the ELISA data and 
the gene expression results at any particular point in time is not necessarily expected. 
Taken together, our findings suggest that the material induced a wound healing response, 
rather than a profound inflammatory response, showing promise for future biomedical 
applications. 
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4. Conclusions 
 
The present study addressed the potential of the new β-type Ti-23Nb-0.7Ta-2Zr-0.5N 
alloy for future use in bone implant applications. Whereas the material was shown to support 
MC3T3-E1 pre-osteoblasts attachment, spreading and proliferation to a similar level with that 
displayed by Ti-6Al-4V control samples, a substantial increase in the differentiation and 
mineralization ability of osteoblasts was observed for Ti-23Nb-0.7Ta-2Zr-0.5N substrate. In 
addition, no significant inflammatory response was elicited in macrophage cells cultured on 
this material. The findings of our short term study demonstrate an excellent in vitro 
biocompatibility, which is critical for the long term success of an osseointegrated implant, 
and suggest that this material holds promise to enhance bone formation and reduce 
osseointegration time. However, the clinical relevance of the observation concerning an 
initially better cell behavior on Ti-23Nb-0.7Ta-2Zr-0.5N substrate alloy and its 
biomechanical implications still have to be demonstrated by long-term in vivo studies. 
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Figure caption 
 
Fig. 1. Optical micrograph of the Ti-23Nb-0.7Ta-2Zr-0.5N alloy. 
Fig. 2. The XPS Survey / wide band spectrum of the Ti-23Nb-0.7Ta-2Zr-0.5N alloy. 
Fig. 3. Stress-strain tensile curves until rupture and after loading/unloading cycles between 0 
and 4% of strain (center part) form the Ti-23Nb-0.7Ta-2Zr-0.5N alloy. 
Fig. 4. AFM maps from Ti-23Nb-0.7Ta-2Zr-0.5N (a) and Ti-6Al-4V (b). 
Fig. 5. Fluorescent microscopy images of MC3T3-E1 cells cultured for 3 h and 24 h on Ti-
23Nb-0.7Ta-2Zr-0.5N and Ti-6Al-4V surfaces. Actin microfilaments and vinculin adhesion 
plaques were stained red and green, respectively.  Cells exhibited well-defined cytoskeletal 
organization on both samples.  
Fig. 6. MTT assay, formazan absorbance as a measure of cell proliferation from MC3T3-E1 
cells cultured on Ti-23Nb-0.7Ta-2Zr-0.5N and Ti-6Al-4V surfaces for different times of 
culture. Results are presented as means ±SD (n = 3). 
Fig. 7. Digital images of the analyzed samples showing extracellular matrix mineralization 
(upper panel) and colorimetrically quantitative analysis (lower panel) after 2, 4 and 6 weeks 
of incubation. p < 0.001 compared with the Ti-6Al-4V samples maintained in osteogenic 
induction medium. 
Fig. 8. A) Cytokine gene expression displayed by RAW 264.7 cells cultured onto Ti-23Nb-
0.7Ta-2Zr-0.5N and Ti-6Al-4V surfaces. B) Mean (±SD) levels of cytokines secreted into 
culture media after 24 h and 48 h culture of RAW 264.7 macrophages on test samples, as 
detected by ELISA. p < 0.05, p < 0.001 vs. Ti-6Al-4V; ▪▪▪p < 0.001 vs.  Ti-6Al-4V + 
LPS. 
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